Joben Bio-Medical Co., Ltd.   Report issue

For profit Phase 2
Founded: Pingtung Taiwan (2010)
Status: No NME R&D (2010)

Organization Overview

First Clinical Trial
2014
NCT02289365
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

jbm-tc4 (1 trial)

polyethylene glycol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Radiodermatitis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2